Advertisement McNeil Consumer Healthcare voluntarily recalls certain OTC products - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

McNeil Consumer Healthcare voluntarily recalls certain OTC products

McNeil Consumer Healthcare, a division of McNEIL-PPC, is voluntarily recalling, at the wholesale level, certain lots of TYLENOL 8 Hour, TYLENOL Arthritis Pain, and TYLENOL upper respiratory products, and certain lots of BENADRYL, SUDAFED PE, and SINUTAB products (OTC products) distributed in the US, the Caribbean, and Brazil.

The products were manufactured at the McNeil plant in Fort Washington, PA prior to April 2010, when production at the facility was suspended.

McNeil Consumer Healthcare is initiating the recall as a precautionary measure after an extensive review of past production records found instances where equipment cleaning procedures were insufficient or that cleaning was not adequately documented.

McNeil Consumer Healthcare is also initiating a voluntary recall of certain product lots of ROLAIDS Multi-Symptom Berry Tablets distributed in the US, in order to update the labeling.

The company initiated the recall after determining that the product labeling does not include the language ‘Does not meet USP’ as required by regulation.

McNeil identified the inadequacies as part of a thorough, proactive product quality and process assessment of all McNeil produced products.